Mixed Carcinoma — Trials

Mixed Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

119 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 37
Recruiting: 13
Ph III recruiting: 5
Growth YoY: —
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 21.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (14)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02068794	MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer	active not recruiting	Phase 1 / Phase 2	34	Mayo ClinicOTHER	1	Aug 24, 2026	clinicaltrials
NCT02595879	Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer	active not recruiting	Phase 1	21	National Cancer Institute (NCI)NIH	1	Jul 31, 2026	clinicaltrials